It’s only fair to share… Cendifensine CAS 1034048-49-1 MF C14H17Cl2NO MW286.2 g/mol Methanone, (3,4-dichlorophenyl)[(3S)-3-propyl-3-pyrrolidinyl]- (3,4-dichlorophenyl)[(3S)-3-propylpyrrolidin-3-yl]methanonemonoamine reuptake inhibitor, NOE-115, NOE 115, N4U2JR8GCX, Cendifensine (INNTooltip International Nonproprietary Name) is a monoamine reuptake inhibitor (MRI)[1] related to the amphetamines and cathinones which has not been marketed at this time.[2][3][4] It was first described by 2013[4] and its INNTooltip International Nonproprietary Name was proposed in 2024.[2] The drug has been patented by Noema Pharma, which …
Tag «monoamine reuptake inhibitor»
Pudafensine
It’s only fair to share… Pudafensine CAS 1320346-14-2 MFC17H19NO4 MW 301.34 g/mol 7-{[(1R,3s,5S)-8-azabicyclo[3.2.1]octan-3-yl]oxy}-3-methoxy2H-1-benzopyran-2-onemonoamine reuptake inhibitor, erectile dysfunction, neuropathic pain, NS18313, NS 18313, L9NG7US8GE, IP2015, IP 2015 Pudafensine is a monoamine reuptake inhibitor being developed as a potential treatment for erectile dysfunction (ED) and neuropathic pain. As a drug candidate, it works by preferentially inhibiting the reuptake of dopamine and serotonin. …